Bladder Disorders Clinical Trials

Don't wait, participate! A clinical trial for those with OAB (overactive bladder) is now enrolling. Play an active role in your healthcare and contact us to see if you qualify to participate in this study.

A study of an investigational product for the symptoms of overactive bladder.

This is a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, including tolerability, of ISIS 703802 and to assess the efficacy of different doses and dosing regimens of ISIS 703802 on glucose and lipid metabolism, and liver fat in subjects with Hypertriglyceridemia, Type 2 Diabetes Mellitus (T2DM), and ...

A Humanitarian Use Device trial for patients who have hepatocellular carcinoma of the liver.

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. ClinSearch is enrolling volunteers with a condition called liver fibrosis from NASH in a study testing the effectiveness and safety of an investigational medication.   Qualified participants may receive: -  Study-related medication at no cost-  Study-related medical ...

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. If you have liver fibrosis due to Nonalcoholic Steatohepatitis (NASH), Wake Research Associates is enrolling volunteers with in a study testing an investigational medication. 

People with liver disorder are asked to participate in a research study being conducted by Montefiore Medical Center.

Patients who wish to enroll in a research study should discuss the possibilities with their urologist. The TUCC Clinical Research Department staff remains in constant communication with patients throughout their enrollment in clinical trials. These patients receive all study related medication and procedures at no cost. Participation is voluntary and ...

Clinical research study of an investigational medication in the treatment of people with Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis OR Compensated Liver Cirrhosis.  

In this research study, there are two study phases. In the first phase which last one year, eligible NASH participants will be assigned to receive the investigational drug OCA or placebo. The study treatment will be assigned randomly (like flipping a coin) with two-thirds of the participants assigned to OCA ...